cytosorbents.com (CTSO) - Dhuwit awis saben siji saham

Cytosorbents is developing a global supply network for blood purification systems while maintaining high operational profitability. Revenues are based on the sale of disposable cartridges for intensive care and cardiac surgery. An analysis of cash per share in the GURU.Markets terminal shows that the value of 1.35 is the current metric. The company's strategy relies on organic growth and research contracts with clinics without major mergers.
Rincian metrik komprehensif lan analitis CytoSorbents Corp (CTSO)

This indicator reflects the liquidity level per ordinary share. By analyzing the amount of cash per share, an investor assesses the business's internal margin of safety. The metric is calculated by dividing the total volume of cash and cash equivalents by the number of issued securities. For Cytosorbents (CTSO), this resource is critically important when scaling the supply of CytoSorb filters to the hospital sector. Capital accumulation ensures the company's technological leadership in the fight against cytokine storms.